TP53 and glioblastoma: Over-all, our results strongly suggest that functional reduction of RIOK1 and RIOK2 results in loss of Akt activity and p53 activation to drive cell cycle arrest, chemosensitivity, and apoptosis in Akt-dependent GBM cells with intact p53 (Figure 7).